S1PR2

Iz Wikipedije, slobodne enciklopedije
Idi na navigaciju Idi na pretragu
edit
Sfingozin-1-fosfatni receptor 2
Dostupne strukture
1ZTI
Identifikatori
SimboliS1PR2; AGR16; EDG-5; EDG5; Gpcr13; H218; LPB2; S1P2
Vanjski IDOMIM605111 MGI99569 HomoloGene3118 IUPHAR: S1P2 GeneCards: S1PR2 Gene
Pregled RNK izražavanja
PBB GE EDG5 208537 at tn.png
podaci
Ortolozi
VrstaČovekMiš
Entrez929414739
EnsemblENSG00000175898ENSMUSG00000043895
UniProtO95136P52592
RefSeq (mRNA)NM_004230.3NM_010333.4
RefSeq (protein)NP_004221.3NP_034463.2
Lokacija (UCSC)Chr 19:
10.33 - 10.34 Mb
Chr 9:
20.77 - 20.78 Mb
PubMed pretraga[1][2]

Sfingozin-1-fosfatni receptor 2 (S1PR2, S1P2) je ljudski gen koji kodira G protein spregnuti receptor za koji se vezuje lipidni signalni molekul sfingozin 1-fosfat (S1P).[1]

Funkcija[uredi - уреди | uredi kôd]

Ova protein učestvuje u sfingozin 1-fosfatom indukovanoj ćelijskoj proliferaciji, opstanku, i transkripcionoj aktivaciji.[1]

Reference[uredi - уреди | uredi kôd]

Literatura[uredi - уреди | uredi kôd]

  • Spiegel S (2000). „Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein-coupled receptors.”. Ann. N. Y. Acad. Sci. 905: 54–60. DOI:10.1111/j.1749-6632.2000.tb06537.x. PMID 10818441. 
  • Takuwa Y (2002). „[Regulation of Rho family G proteins and cell motility by the Edg family of sphingosin 1-phosphate receptors]”. Tanpakushitsu Kakusan Koso 47 (4 Suppl): 496–502. PMID 11915348. 
  • MacLennan AJ, Browe CS, Gaskin AA, et al. (1994). „Cloning and characterization of a putative G-protein coupled receptor potentially involved in development.”. Mol. Cell. Neurosci. 5 (3): 201–9. DOI:10.1006/mcne.1994.1024. PMID 8087418. 
  • Yamaguchi F, Tokuda M, Hatase O, Brenner S (1996). „Molecular cloning of the novel human G protein-coupled receptor (GPCR) gene mapped on chromosome 9.”. Biochem. Biophys. Res. Commun. 227 (2): 608–14. DOI:10.1006/bbrc.1996.1553. PMID 8878560. 
  • Van Brocklyn JR, Tu Z, Edsall LC, et al. (1999). „Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218.”. J. Biol. Chem. 274 (8): 4626–32. DOI:10.1074/jbc.274.8.4626. PMID 9988698. 
  • Ancellin N, Hla T (1999). „Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5.”. J. Biol. Chem. 274 (27): 18997–9002. DOI:10.1074/jbc.274.27.18997. PMID 10383399. 
  • Windh RT, Lee MJ, Hla T, et al. (1999). „Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins.”. J. Biol. Chem. 274 (39): 27351–8. DOI:10.1074/jbc.274.39.27351. PMID 10488065. 
  • An S, Zheng Y, Bleu T (2000). „Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5.”. J. Biol. Chem. 275 (1): 288–96. DOI:10.1074/jbc.275.1.288. PMID 10617617. 
  • Himmel HM, Meyer Zu Heringdorf D, Graf E, et al. (2000). „Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes.”. Mol. Pharmacol. 58 (2): 449–54. PMID 10908314. 
  • Hla T (April 2001). Sphingosine 1-phosphate receptors.. 64. pp. 135–142. PMID 11331101. 
  • Mazurais D, Robert P, Gout B, et al. (2002). „Cell type-specific localization of human cardiac S1P receptors.”. J. Histochem. Cytochem. 50 (5): 661–70. PMID 11967277. 
  • Osada M, Yatomi Y, Ohmori T, et al. (2003). „Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist.”. Biochem. Biophys. Res. Commun. 299 (3): 483–7. DOI:10.1016/S0006-291X(02)02671-2. PMID 12445827. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). „Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. DOI:10.1073/pnas.242603899. PMC 139241. PMID 12477932. //www.ncbi.nlm.nih.gov/pmc/articles/PMC139241/. 
  • Vogler R, Sauer B, Kim DS, et al. (2003). „Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing.”. J. Invest. Dermatol. 120 (4): 693–700. DOI:10.1046/j.1523-1747.2003.12096.x. PMID 12648236. 
  • Kaneider NC, Lindner J, Feistritzer C, et al. (2005). „The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor.”. Faseb J. 18 (11): 1309–11. DOI:10.1096/fj.03-1050fje. PMID 15208267. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). „The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).”. Genome Res. 14 (10B): 2121–7. DOI:10.1101/gr.2596504. PMC 528928. PMID 15489334. //www.ncbi.nlm.nih.gov/pmc/articles/PMC528928/. 
  • Sanchez T, Thangada S, Wu MT, et al. (2005). „PTEN as an effector in the signaling of antimigratory G protein-coupled receptor.”. Proc. Natl. Acad. Sci. U.S.A. 102 (12): 4312–7. DOI:10.1073/pnas.0409784102. PMID 15764699. 
  • Sanchez T, Skoura A, Wu MT, et al. (2007). „Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN.”. Arterioscler. Thromb. Vasc. Biol. 27 (6): 1312–8. DOI:10.1161/ATVBAHA.107.143735. PMID 17431187. 

Vidi još[uredi - уреди | uredi kôd]

Spoljašnje veze[uredi - уреди | uredi kôd]